Introduction {#Sec1}
============

Protein ubiquitination involves a series of enzymatic reactions such as E1 activation, E2 conjugation, and E3 ligation, resulting in the conjugation of single or multiple ubiquitin proteins at a target lysine residue \[[@CR1]\]. Numerous substrate proteins with ubiquitination sites have been characterized to date, owing to the emergence of high-throughput mass spectrometry-based proteomics approaches \[[@CR2]--[@CR4]\]. Identified to play key roles in transcriptional regulation, signal transduction, development, apoptosis, endocytosis, cell proliferation and cancers, ubiquitination of the lysine residue has been regarded as an essential mediator of various biological processes \[[@CR5]--[@CR7]\]. Among the enzymes that catalyze protein ubiquitination, E3 ligases are particularly important for the recognition of substrate sites to facilitate ubiquitin-mediated protein degradation \[[@CR8]\]. The relationships between E3 ligase and substrates are complex. Multiple substrates could be targeted by a single E3 ligase; alternatively, multiple E3 ligases could catalyze the ubiquitination of a single substrate \[[@CR9]\]. These substrate-enzyme correlations could be used to construct E3-specific regulatory networks and map to the associated cellular pathways, making possible the characterization of complex cellular processes and functional analysis of E3-sbustrate relationships \[[@CR9]\]. This approach has allowed the discovery of the role that anaphase-promoting complex (APC)/cyclosome plays in modulating key targets of the cell cycle, such as cyclins and their related E3 ligases \[[@CR10]--[@CR12]\].

To date, a significant amount of research efforts have been invested towards the characterization of E3 structures and examination of the mechanisms underlying E3-mediated regulatory networks, as well as E3-related diseases \[[@CR13]--[@CR21]\]. Based on their catalytic mechanisms in the ubiquitination process, E3 ligases can be classified into three major types: the HECT (homologous to E6-AP C-terminus), the RING (really interesting new gene), and U-box domain types \[[@CR22]\]. The HECT-type is responsible for catalyzing the attachment of ubiquitin to substrate proteins. In contrast, the RING-type and U-box-type, similar in both structure and function, facilitate the interaction between an E2 enzyme and the target proteins. Regardless of the types, the significance of E3-mediated ubiquitination is obvious from their association with diseases \[[@CR23]\]. Several studies have suggested that the inhibition of E3 ligases may cause growth suppression or cell death, as evidenced by the over-expression of Mdm2/Hdm2, IAPs, and SCF in various human cancers \[[@CR24]\]. Therefore, regulation of E3 ligase activities and functions may be a promising approach for cancer treatments.

Many databases and tools have been developed to aid in the study of E3 ligases. For example, E3Miner \[[@CR25]\] offers a text mining approach to identify ubiquitin-protein ligases, whereas E3Net \[[@CR9]\] allows users to search through a collection of 1671 E3-substrate relationships among 493 E3s and 1277 substrates in 42 organisms. In contrast, by analyzing protein sequence similarities, domains, and distributions across different species, Sakiyama et al*.* \[[@CR26]\] constructed a useful database for the exploration of proteins involved in the ubiquitin signaling cascade. Unfortunately, the present accumulation of large-scale ubiquitinome data demands for the development of tools that investigate the regulatory networks of E3 ligases and their substrates. Here, we present a new strategy that utilizes an interactive network viewer to assist with the discovery of novel protein ubiquitination networks. Furthermore, to effectively investigate the relationships between E3 ligases and their substrates, metabolic pathways and protein-protein interactions (PPIs) were integrated to construct comprehensive protein ubiquitination networks. The ability of the proposed method to identify E3 ligase-mediated ubiquitination networks and their biological significance was demonstrated by case studies. The results indicated that, despite the current limited knowledge about regulatory relationship between E3 ligases and ubiquitinated proteins, our approach could uncover potential E3 ligase-substrate relationships based on based on protein-protein interaction information and substrate site specificities.

Materials and method {#Sec2}
====================

Construction of the protein ubiquitination networks involved collection of E3 ligase and ubiquitinated protein data, integration of ubiquitinated proteins' functional data, computational identification of ubiquitination sites based on substrate motifs, as well as network construction using protein-protein interactions and metabolic pathways (Fig. [1](#Fig1){ref-type="fig"}). A network viewer was employed to provide a visualization of the ubiquitination regulatory network, with implemented functional information, for a group of proteins of interest. The detailed workflow is described as follows.Fig. 1System flow of protein ubiquitination network construction

Data collection of E3 ubiquitin ligases and ubiquitinated proteins {#Sec3}
------------------------------------------------------------------

Experimentally validated E1 activating, E2 conjugating, and E3 ligating enzyme data were obtained from various sources. From UUCD-Version 1.0 \[[@CR27]\], seven distinct E1 activating enzymes were collected. From E3Net, UUCD \[[@CR27]\], hUbiquitome \[[@CR28]\], and UniProtKB \[[@CR29]\], 494 non-redundant E3 ubiquitin ligases and their biological functions were extracted. In addition, a total of 46 non-redundant E2 conjugating enzymes were collected from UUCD \[[@CR27]\], hUbiquitome \[[@CR28]\] and UniProtKB \[[@CR29]\]. Experimentally verified ubiquitination sites from dbPTM \[[@CR30]--[@CR32]\] were also included. Next, search keywords, such as "ubiquitinated", "ubiquitination", "ubiquitylated", or "ubiquitylation", were entered on the PubMed database to extract ubiquitinated protein data from research articles. Specifically, full texts of the matched research articles were manually reviewed to ensure that the exact ubiquitinated peptide and modified lysine residue information were extracted. Finally, redundant data were removed, generating a total of 41,392 ubiquitinated lysines from 12,786 ubiquitinated human proteins.

Characterization of protein ubiquitination sites {#Sec4}
------------------------------------------------

To characterize the amino acid composition of protein ubiquitination sites, WebLogo \[[@CR33], [@CR34]\] was utilized to generate the relative frequency of the corresponding amino acid at each position around the ubiquitination sites as represented by the graphical sequence logo. As well, to further discriminate the amino acid composition of ubiquitinated sites from their non-ubiquitinated counterparts, TwoSampleLogo \[[@CR35]\] was adopted to display statistically significant differences in position-specific symbol compositions. The inherent complexity of large-scale ubiquitinome data may make it difficult to uncover conserved motifs. To overcome this problem, MDDLogo \[[@CR36]\] was applied to identify potential motifs for the curated protein ubiquitination sites. MDDLogo is a program that uses the maximal dependence decomposition (MDD) approach to discover conserved motifs from groups of aligned signal sequences through a recursive process that divides the data sets into tree-like subgroups. The effectiveness of MDDLogo has been demonstrated in the identification of substrate motifs for phosphorylation \[[@CR37]--[@CR40]\], *S*-nitrosylation \[[@CR41]\], O-GlcNAcylation sites \[[@CR42]\], *S*-glutathionylation \[[@CR43]\], as well as ubiquitin conjugation sites \[[@CR2]\].

Data integration for functional investigation of ubiquitinated proteins {#Sec5}
-----------------------------------------------------------------------

To investigate the biological significance of ubiquitinated proteins, various biological databases, such as Gene Ontology (GO) \[[@CR44]\], InterPro \[[@CR45]\], as well as KEGG Diseases and Pathways \[[@CR46]\], were incorporated. To provide comprehensive functional annotations of proteins associated with ubiquitination, the ubiquitinated proteins were classified according to their molecular functions, biological processes, and cellular components. Since ubiquitination is known to regulate the cellular localization, interactions, and degradation of proteins \[[@CR47]--[@CR49]\], the biological roles of ubiquitination sites within a specific protein domain could be inferred from the functional annotation of the domain. For this purpose, essential protein family, domain, and functional site information was obtained from InterPro \[[@CR45]\], a database which integrates data from various sources such as the PROSITE \[[@CR50]\], PRINTS \[[@CR51]\], Pfam \[[@CR52]\], and ProDom \[[@CR53]\].

Network construction using protein-protein interactions and metabolic pathways {#Sec6}
------------------------------------------------------------------------------

Substantial evidence supports the role that protein ubiquitination plays in the regulation of cellular processes. Thus, by integrating experimentally validated mammalian E3 ubiquitin ligases and their functional information, we hoped to provide a foundation for navigating ubiquitination regulatory networks in mammals. To facilitate the exploration of regulatory relationships between E3 ligases and their ubiquitinated substrates, associated metabolic pathways and protein-protein interactions (PPIs) were included for the comprehensive construction of protein ubiquitination networks. The human metabolic pathways were extracted from KEGG \[[@CR54]\]. Experimentally verified PPIs were obtained from over ten PPI databases (Additional file [1](#MOESM1){ref-type="media"}: Table S1). Potential PPIs predicted based on co-regulation, co-occurrence in the literature, co-expression, and genomic context were curated from the STRING database \[[@CR55]\]; each interaction included a confidence score calculated by the STRING built-in function.

Next, a graph theory \[[@CR56], [@CR57]\] approach has been adopted to illustrate the relationships between E3 ligases and substrates. Specifically, we use a directed and cyclic graph *G* = ( *V* , *E* ) to symbolize a protein ubiquitination network, where *x* , *y* ∈ *V* and ( *x* , *y* ) ∈ *E*. The E3 ligases and substrate proteins were represented by *x* and *y*, respectively, and protein ubiquitination was denoted by (*x*, *y*) ∈ *E* to indicate the recognition of a specific substrate *y* by E3 ligase *x* (Additional file [2](#MOESM2){ref-type="media"}: Figure S1). Due to limited knowledge about ubiquitinated substrates that are recognized by E3 ligases, (*x*, *y*) could also represent a type of protein-protein interaction between E3 ligase *x* and ubiquitinated protein *y*. We used *V* to refer to all human proteins and *E*, to all experimentally confirmed PPIs. Cytoscape \[[@CR58]\], a publicly available network viewer, was employed for the visualization of regulatory networks among E3 ligases and ubiquitinated substrates.

Results and discussion {#Sec7}
======================

Data statistics in this investigation {#Sec8}
-------------------------------------

Data used for building the protein ubiquitination networks in this study were experimentally validated and supported with 39,814 research articles. Over 500 research articles were manually reviewed via a text mining method. In total, 41,392 ubiquitination sites from 12,786 ubiquitinated proteins in humans were extracted from 406 literatures. After removing redundant data among heterogeneous online resources, 494 experimentally verified human E3 ubiquitin ligases remained in the resulting data. PPIs between E3 ligases and ubiquitinated proteins were retrieved to deduce potential regulatory relationships between E3 ligases and ubiquitinated substrates to compensate for the limited information about E3 ligase targets. As shown in Table [1](#Tab1){ref-type="table"}, 9,271 physical PPIs between 426 E3 ligases and 2,649 ubiquitinated proteins were curated. In particular, by incorporating the substrate motifs identified by the MDDLogo ubiquitination site prediction method \[[@CR36]\]*,* potential substrates of E3 ligases could be inferred from the 27,227 PPIs between E3 ligases and other proteins. Moreover, 377,117 PPIs that appeared to involve ubiquitinated proteins could be integrated for the investigation of their functional associations in the context of ubiquitination.Table 1Data statistics in this workData contentNumber of recordsUbiquitinated protein (potential E3 substrates)12,786Ubiquitination sites41,392E3 ubiquitin ligases494PPIs between E3 ligases and other proteins27,227PPIs between E3 ligases and ubiquitinated proteins9,271E3 ligases interacting with ubiquitinated proteins436Ubiquitinated proteins interacting with E3 ligases2,649Supported articles39,814

Substrate specificities of human ubiquitination sites {#Sec9}
-----------------------------------------------------

The entropy plots generated by the sequence logo was used to graphically visualize the amino acid sequences flanking the substrate sites (at position 0). This allows for the easy observation of amino acid conservation surrounding the ubiquitination sites. Figure [2a](#Fig2){ref-type="fig"} shows Leu (L), Glu (E), and Ala (A) to be the most conserved amino acid residues as indicated by the position-specific amino aicd composition around the ubiquitinated lysines. Furthermore, using TwoSampleLogo, the differences in position-specific amino acid composition between ubiquitinated and non-ubiquitinated sites were revealed (Fig. [2b](#Fig2){ref-type="fig"}). The residues surrounding the ubiquitination sites were significantly enriched with Ala (A), Asp (D), Glu (E), Leu (L), Gly (G) and Thr (T), and depleted in Cys (C), His (H), Arg (R), Trp (W) and Met (M) (*p* \< 0.005).Fig. 2Amino acid composition of protein ubiquitination sites. **a** The frequency plot of ubiquitinated sites. **b** The compositional biases of amino acids around ubiquitination sites compared to the non-ubiquitination sites

To overcome the difficulty of discovering conserved motifs from large-scale ubiquitinome data, the MDDLogo clustering method was adopted to search for substrate motifs from the curated human ubiquitination sites using a 13-mer window length. MDDLogo identified a total of nine subgroups containing conserved motifs from non-homologous human ubiquitination sites (Additional file [3](#MOESM3){ref-type="media"}: Table S2). While subgroup 1 (241 ubiquitination sites) contained the conserved amino acid composition at positions +3 and +5, the conserved motif of subgroup 2 included Arginine (R), Lysine (K), Phenylalanine (F), Tyrosine (Y) and Tryptophan (W) residues at position +5. The conserved motifs of Subgroups 3 and 8 comprised Glutamic acid (E), Aspartic acid (D), Glutamine (Q) and Asparagine (N) residues at positions +3 and -2, respectively. In contrast, the remaining subgroups consisted of Phenylalanine (F), Tyrosine (Y) and Tryptophan (W) residues at various specific positions in their conserved motifs. Thus, substrate motifs for ubiquitination sites may be determined by the position-specific conservation of Phenylalanine (F), Tyrosine (Y) and Tryptophan (W) residues. Furthermore, MDDLogo could be utilized to identify putative ubiquitination sites and potential interaction between E3 ligase and ubiquitinated proteins based on substrate motif conservation.

Functional associations of E3 ligases and ubiquitinated proteins {#Sec10}
----------------------------------------------------------------

Distributions of GO annotations for E3 ligases and ubiquitinated proteins categorized according to their corresponding biological processes, molecular functions and cellular components are provided in (Additional file [4](#MOESM4){ref-type="media"}: Table S3 and Additional file [5](#MOESM5){ref-type="media"}: Table S4), respectively. Following the InterPro annotation, the most abundant protein domain for E3 ligases appeared to belong to the "Zinc finger, RING-type RNA" (Table [2](#Tab2){ref-type="table"}). In a genome-wide study of E3 ligases, it was suggested that the mammalian genomes encode more than 600 potential RING finger E3s \[[@CR59]\]. E3 ligases containing the RING finger domain facilitate the interaction between an E2 enzyme and a substrate to mediate the transfer of ubiquitin from E2 to the target \[[@CR60], [@CR61]\]. On the other hand, those with the HECT domain are involved in the regulation of cellular trafficking, immune response, cellular growth and proliferation \[[@CR62]\]. The HECT domain containing E3 ligases form a catalytic intermediate with ubiquitin and is responsible for the catalysis of two reactions: 1) transesterification reaction, in which ubiquitin from the cysteine residue at the E2 active site is transferred to another cysteine residue in the HECT domain \[[@CR60]\]; 2) the subsequent attack of a substrate lysine on the thioester of the ubiquitin-bound HECT domain \[[@CR63]\] (Additional file [6](#MOESM6){ref-type="media"}: Figure S2). Whereas the C-terminus of the HECT domain is more conserved, the N-terminus, the part that mediates substrate targeting, is more diverse \[[@CR62]\].Table 2The distribution of top 20 functional domains for human E3 ligasesNo.InterPro IDDomain termsNumber of proteins% Total1IPR001680WD40 repeat28757.5150 %2IPR006652Kelch repeat type 16813.6273 %3IPR000408Regulator of chromosome condensation, RCC15511.0220 %4IPR001841Zinc finger, RING-type5410.8216 %5IPR000315Zinc finger, B-box489.6192 %6IPR003877SPla/RYanodine receptor SPRY387.6152 %7IPR013069BTB/POZ285.6112 %8IPR000569HECT285.6112 %9IPR001202WW/Rsp5/WWP285.6112 %10IPR020683Ankyrin repeat-containing domain275.4108 %11IPR001496SOCS protein, C-terminal255.0100 %12IPR002867Zinc finger, C6HC-type234.6092 %13IPR018957Zinc finger, C3HC4 RING-type224.4088 %14IPR001258NHL repeat214.2084 %15IPR011705BTB/Kelch-associated153.0060 %16IPR002110Ankyrin repeat142.8056 %17IPR000571Zinc finger, CCCH-type112.2044 %18IPR001876Zinc finger, RanBP2-type112.2044 %19IPR011016Zinc finger, RING-CH-type112.2044 %20IPR001452Src homology-3 domain102.0040 %

According to the annotation information on InterPro, approximately 70 % of established ubiquitination sites are mapped to specific functional domains, suggesting that ubiquitination may modulate a variety of biological functions. The top 50 InterPro functional domains containing ubiquitinated sites in humans are given in Table [3](#Tab3){ref-type="table"}. It appeared that most ubiquitination sites could be found in the MHC class I (alpha chain) protein domains. It has been reported that viral proteins could induce the degradation of the histocompatibility complex (MHC) class I protein in the endoplasmic reticulum and at the cell surface by ubiquitinating the MHC class I domain \[[@CR64]\]. The immunoglobulin C1-set domain, or classical Ig-like domains that resemble the antibody constant domain, is another domain found to be enriched with ubiquitinated sites. Interestingly, these domains were found exclusively in mediators of immune response, including various T-cell receptors, MHC class I and II complexes \[[@CR65]\].Table 3Distribution of the top 50 functional domains covering ubiquitination sitesNo.Domain (InterPro) IDDomain (InterPro) termsNumber of sites% Total1IPR001039MHC class I, alpha chain, alpha1/alpha216253.6574 %2IPR003597Immunoglobulin C1-set13212.9732 %3IPR001680WD40 repeat10432.3475 %4IPR002017Spectrin repeat10122.2777 %5IPR010579MHC class I, alpha chain, C-terminal7291.6408 %6IPR003961Fibronectin, type III4691.0556 %7IPR000504RNA recognition motif domain4190.9431 %8IPR000719Protein kinase, catalytic domain3380.7607 %9IPR013098Immunoglobulin I-set2320.5222 %10IPR020683Ankyrin repeat-containing domain2300.5177 %11IPR017868Filamin/ABP280 repeat-like2120.4772 %12IPR006209EGF-like domain1790.4029 %13IPR001715Calponin homology domain1770.3984 %14IPR010630Neuroblastoma breakpoint family (NBPF) domain1680.3781 %15IPR001452Src homology-3 domain1670.3759 %16IPR006652Kelch repeat type 11580.3556 %17IPR000408Regulator of chromosome condensation, RCC11570.3534 %18IPR000225Armadillo1560.3511 %19IPR004088K Homology domain, type 11540.3466 %20IPR001650Helicase, C-terminal1460.3286 %21IPR002126Cadherin1450.3264 %22IPR000048IQ motif, EF-hand binding site1430.3219 %23IPR000083Fibronectin, type I1430.3219 %24IPR000626Ubiquitin1420.3196 %25IPR000008C2 calcium-dependent membrane targeting1350.3038 %26IPR001806Small GTPase superfamily1250.2813 %27IPR001245Serine-threonine/tyrosine-protein kinase catalytic domain1250.2813 %28IPR000433Zinc finger, ZZ-type1230.2768 %29IPR001478PDZ domain1220.2746 %30IPR001849Pleckstrin homology domain1200.2701 %31IPR011545DNA/RNA helicase, DEAD/DEAH box type, N-terminal1120.2521 %32IPR019787Zinc finger, PHD-finger1110.2498 %33IPR001440Tetratricopeptide TPR-11110.2498 %34IPR001202WW/Rsp5/WWP1100.2476 %35IPR018108Mitochondrial substrate/solute carrier1100.2476 %36IPR001781Zinc finger, LIM-type1060.2386 %37IPR001101Plectin repeat1040.2341 %38IPR002049EGF-like, laminin1000.2251 %39IPR002429Cytochrome c oxidase subunit II C-terminal960.2161 %40IPR011759Cytochrome C oxidase subunit II, transmembrane domain960.2161 %41IPR003439ABC transporter-like910.2048 %42IPR001487Bromodomain910.2048 %43IPR018502Annexin repeat880.1981 %44IPR000980SH2 domain860.1936 %45IPR003008Tubulin/FtsZ, GTPase domain770.1733 %46IPR001421ATPase, F0 complex, subunit 8, mitochondrial, Metazoan750.1688 %47IPR013069BTB/POZ750.1688 %48IPR003959ATPase, AAA-type, core740.1666 %49IPR007087Zinc finger, C2H2740.1666 %50IPR000197Zinc finger, TAZ-type740.1666 %

Network analysis for a group of interested proteins {#Sec11}
---------------------------------------------------

To allow users to efficiently search for the proteins of their interest, a convenient interactive network viewer was implemented in the proposed method implemented an interactive network viewer. An example of constructing a protein ubiquitination network using our approach is illustrated in (Additional file [7](#MOESM7){ref-type="media"}: Figure S3). The network was built with four E3 ligases, 14 ubiquitinated proteins and three other proteins. While the established interactions between the four E3 ligases and 14 ubiquitinated proteins were immediately recognized, three other proteins interacting with two of the E3 ligases were also revealed as potential ubiquitinated substrates. For instance, E3 ligase MDM2 was predicted to target Forkhead box protein O3 (FOXO3) for ubiquitination. This is consistent with a recent study supporting MDM2 to be an E3 ligase responsible for the ubiquitin-mediated degradation of FOXO3 \[[@CR66]\]. As well, our approach could provide the potential ubiquitination sites and the corresponding substrate motifs for a specific protein. Furthermore, for a specific E3 ligase and their interacting ubiquitinated proteins, the analysis could even be extended to exploring their functional associations and creating a comprehensive ubiquitin regulatory network.

A case study of the discovered E3 ligases associated with the regulation of p53 {#Sec12}
-------------------------------------------------------------------------------

In cases where information is limited with respect to the interaction between an E3 ligase and its corresponding substrates, our strategy could still identify the potential E3 ligases that may target a specific ubiquitinated protein. A case study is shown in Fig. [3](#Fig3){ref-type="fig"}, demonstrating the ability of the proposed method to construct an interaction map for the ubiquitination of tumor suppressor p53 (TP53). The resulting network is consistent with the literature. As a transcription factor, the tumor suppressor protein p53 responds to stress such as DNA damage by inducing cell cycle arrest and apoptosis \[[@CR67]\]. Recent evidence has established that MDM2, a RING oncoprotein and a negative regulator of p53 \[[@CR24]\], modulates the proteasomal degradation of p53 via a RING-finger-dependent manner \[[@CR68]--[@CR72]\]. Yet, our approach discovered other E3 ligases that may also regulate the ubiquitination of p53. Thus, the proposed strategy has the ability to uncover potential substrates for a specific E3 ligase, as well as potential E3 ligases for ubiquitinated proteins.Fig. 3A case study of the discovered E3 ligases associated with the regulation of *tumor suppressor p53* (TP53)

Conclusion {#Sec13}
==========

In an attempt to characterize the regulatory role protein ubiquitination plays in a variety of biological processes, we combined the information of E3 ligases, ubiquitinated proteins, and protein-protein interactions to construct a comprehensive network of E3 ligases and their ubiquitinated substrates. Designed to serve as not only a meaningful platform for investigating E3-substrate regulatory networks but also a new strategy to uncover potential E3 ligases for ubiquitinated substrates, the proposed approach allows for the efficient characterization of protein ubiquitination networks from large-scale ubiquitinome data. With access to more updated data, the proposed scheme can be further refined for the study of E1 activating enzymes, E2 conjugating enzymes, and E3 ubiquitin ligases. Also, recent publications regarding the structural environment of experimentally validated ubiquitination sites based on protein tertiary structures \[[@CR73]--[@CR76]\] could be incorporated to infer the functional interactions between the enzymes and substrates. Finally, confirmed functional annotations of ubiquitination sites could be extracted from the literature via a more advanced information retrieval system to collect more adequate information required for further functional analyses.
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